Abstract:Background: The proatherogenic effect of LDL cholesterol and antiatherogenic effect of HDL cholesterol have been confirmed in general population. But controversy arises on the protective role of HDL cholesterol and predictive superiority of apolipoprotein (apo)B among CAD patients. Objectives: This study was to identify the association of different lipid measurements with CAD prognosis and compare their prognostic significance. Methods: The study cohort included 1916 CAD patients who were 40-85 years of age. Cox proportional hazards regression models were used to estimate the association of baseline 6 lipid factors (HDL cholesterol, LDL cholesterol, total cholesterol, non-HDL cholesterol, apoA-I, and apoB) and 3 ratios with all-cause and CVD mortality. Results: During a median follow-up of 3.1 years, 147 deaths were recorded, 113 of which were due to CVD. When lipid factors were categorized, HDL cholesterol showed a U-shape association with all-cause and CVD mortality after adjustment for major CVD risk factors. The multivariable-adjusted hazard ratios in HDL cholesterol<40 mg/dL and ≥70 mg/dL groups were 2.09 (95% CI 1.37-3.20) and 3.06 (95% CI 1.08-8.70) for all-cause mortality, and 2.59 (95% CI 1.53-4.38) and 4.83 (95% CI 1.47-15.8) for CVD mortality, compared with HDL cholesterol between 40 and 49 mg/dL group. ApoA-I level was inversely associated with the risk of all-cause and CVD mortality. The multivariable-adjusted hazard ratios across quartiles of apoA-I were 1.00, 0.59 (95% CI 0.38-0.92), 0.43 (95% CI 0.26-0.70), and 0.56 (95% CI 0.35-0.88) for all-cause mortality (P for trend =0.004), and 1.00, 0.55 (95% CI 0.33-0.91), 0.39 (95% CI 0.22-0.70), and 0.57 (95% CI 0.34-0.95) for CVD mortality (P=0.007). Serum LDL cholesterol, apoB, LDL/HDL ratio, and apoB/apoA-I ratio were positively associated with the risk of CVD mortality. Patients with LDL cholesterol ≥190 mg/dL had a 4.35-fold risk of CVD mortality (95% CI 1.34-14.2) compared with patients with LDL cholesterol<70 mg/dL. Patients with apoB ≥110 mg/dL had a 2.06-fold risk of CVD mortality (95% CI 1.10-3.85) compared with patients with apoB<90 mg/dL. The multivariable-adjusted hazard ratios in highest quartiles of LDL/HDL ratio and apoB/apoA-I ratio were 1.61 (95% CI 1.01-2.56) and 2.00 (95% CI 1.21-3.31) for all-cause mortality, and 1.74 (95% CI 1.02-2.96) and 2.33 (95% CI 1.32-4.14) for CVD mortality compared with the lowest quartiles. After further pair-wise comparison, LDL/HDL ratio and LDL cholesterol had stronger associations with all-cause and CVD mortality than other proatherogenic measurements. Conclusions: There was a U-shape association between HDL cholesterol and CVD mortality among CAD patients. High levels of LDL cholesterol and apoB, high LDL/HDL ratio and apoB/apoA-I ratio, and low level of apoA-I were independently associated with an increased risk of CVD mortality among Chinese CAD patients.

Prognostic significance of cholesterol level in chronic heart failure

Remnant Cholesterol Predicts Long-term Mortality of Patients with Metabolic Dysfunction-associated Fatty Liver Disease

Significance of Serum Albumin for Chronic Heart Failure and Its Prognosis

Associations of High Hdl Cholesterol Level with All-Cause Mortality in Patients with Heart Failure Complicating Coronary Heart Disease

The effects of serum iron level without anemia on long-term prognosis of patients with coronary heart disease complicated with chronic heart failure: a retrospective cohort study

Serum Free Fatty Acids Independently Predict Adverse Outcomes in Acute Heart Failure Patients

[Association of High-Density Lipoprotein Cholesterol with Risk of Cardiovascular Disease Mortality].

Serum Cholesterol Efflux Capacity is an Independent Predictor of All-cause and Cardiovascular Mortality in Patients With Coronary Artery Disease

The relationship between serum high-mobility group box-1 and prognosis of chronic heart failure

Study on the Correlation of Serum Lipoprotein (a),pro-BNP,Troponin I and Total Bilirubin with the Prognosis of Patients with Chronic Heart Failure

Serum Ferritin and the Risk of Short-Term Mortality in Critically Ill Patients with Chronic Heart Failure: a Retrospective Cohort Study

Clinical significance of change of various indexes levels in patients with coronary heart disease complicating chronic chro-nic heart failure

Prognostic Usefulness of Serum Cholesterol Efflux Capacity in Patients With Coronary Artery Disease.

Association between serum cystatin C levels and prognosis in heart failure patients

Long-term Prognostic Value of High-Sensitivity C-reactive Protein and Its Combination with Serum Cholesterol in Acute Coronary Syndrome

Abstract P268: Serum Lipids, Apolipoproteins, and Mortality among Coronary Artery Disease Patients

Correlation Between Thyroid Hormone Levels and Long-Term Survival in Patients with Chronic Heart Failure

Serum Chemerin as a Novel Prognostic Indicator in Chronic Heart Failure.

The Association Between Levels of Serum Homocysteine and Chronic Heart Failure

Correlation of vasostatin-2 level with severity and prognosis of chronic heart failure

The impact of serum total bilirubin level on long-term prognosis in patients with chronic heart failure]